Imatinib Tablets Ip 400 Mg

Product Description

Imatinib Tablets Ip 400 Mg contains the active ingredient imatinib mesylate. This works by inhibiting the activity of specific tyrosine kinases, including BCR-ABL, c-KIT, and PDGF-R, which are involved in the abnormal growth and proliferation of cancer cells. Imatinib is a tyrosine kinase inhibitor used in the treatment of various cancers, including chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GISTs), and certain types of acute lymphoblastic leukemia (ALL). By blocking these kinases, imatinib helps to inhibit the growth of cancer cells and induce their death. Imatinib Tablets Ip 400 Mg works by inhibiting the activity of specific tyrosine kinases, including BCR-ABL, c-KIT, and PDGF-R, which are involved in the abnormal growth and proliferation of cancer cells.

Specification